Effect of combined treatment with curcumin and candesartan on ischemic brain damage in mice

Journal of Stroke and Cerebrovascular Diseases

Volumn 20, Issue 6, 2011, Pages 541-548

  Awad, Azza S ^a  

^a Al Azhar University   (Egypt)

Author keywords

antioxidant; Blood flow; cerebral ischemia; heart rate; lipid peroxidation; nitric oxide

Indexed keywords

CANDESARTAN; CURCUMIN; GLUTATHIONE TRANSFERASE; LIPID PEROXIDE; NITRIC OXIDE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD FLOW VELOCITY; BRAIN BLOOD FLOW; BRAIN HOMOGENATE; COLOR; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; ENZYME ACTIVITY; HEART RATE; HYPOXIC ISCHEMIC ENCEPHALOPATHY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT RESPONSE;

ANIMALS; ANTIOXIDANTS; BENZIMIDAZOLES; BLOOD FLOW VELOCITY; BRAIN; CEREBROVASCULAR CIRCULATION; CURCUMIN; DISEASE MODELS, ANIMAL; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; GLUTATHIONE TRANSFERASE; HEART RATE; INFARCTION, MIDDLE CEREBRAL ARTERY; LIPID PEROXIDATION; MALE; MICE; NEUROPROTECTIVE AGENTS; REGIONAL BLOOD FLOW; SUPEROXIDE DISMUTASE; TETRAZOLES; TIME FACTORS;

EID: 81155138885     PISSN: 10523057     EISSN: 15328511     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2010.03.008     Document Type: Article

References (65)

1. D.C. Rogers, C.A. Campbell, and L. Jennifer Correlation between motor impairment and infarct volume after permanent and transient middle artery occlusion in rat Stroke 28 1997 2060 2065
2. W. Hacke, M. Kaste, and C. Fieschi Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study JAMA 274 1995 1017 1025
3. Y. Yamori, H. Horie, and H. Handa Pathogenetic similarity of strokes in stroke-prone spontaneously hypertensive rats and humans Stroke 7 1976 46 53
4. T.B. Müller, O. Haraldseth, and R.A. Jones Perfusion and diffusion-weighted MR imaging for in vivo evaluation of treatment with U74389G in a rat stroke model Stroke 26 1995 1453 1458
5. M.D. Ginsberg Adventures in the pathophysioogy of brain ischemia: Penumbra, gene expression, neuroprotection. The 2002 Thomas Willis Lecture Stroke 34 2003 214 223 (Pubitemid 36070826)
6. Y. Wang, C.F. Chang, and H.L. Chen Dietary supplementation with blueberries, spinach or spirulina reduces ischemic brain damage Exp Neurol 193 2005 75 84 (Pubitemid 40463269)
7. J. Miquel An update on the mitochondrial-DNA mutation hypothesis of cell aging Mutat Res 275 1992 209 216
8. B. Halliwell Reactive oxygen species and the central nervous system J Neurochem 59 1992 1609 1623
9. T. Mokudai, I.A. Ayoub, and Y. Sakakibara Delayed treatment with nicotinamide (vitamin B3) improves neurological outcome and reduces infarct volume after transient focal cerebral ischemia in Wistar rat Stroke 31 2000 1679 1685 (Pubitemid 30437523)
10. L.H. Lindholm, H. Ibsen, and B. Dahlöf LIFE Study Group. Cardiovascular morbidity and mortality in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol Lancet 359 2002 1004 1010 (Pubitemid 34286537)
11. A. Fournier, O. Godefroy, and R. Oprisiu Converting enzyme inhibitor or AT1-receptor blocker for decreasing long-term mortality in patients with stroke history and renal dysfunction? Stroke 34 2003 8 9 (Pubitemid 36070790)
12. M. Iwai, H.W. Liu, and R. Chen Possible inhibition of focal cerebral ischemia by angiotensin II type 2 receptor stimulation Circulation 110 2004 843 848 (Pubitemid 39096013)
13. M. Iwai, R. Chen, and A. Ide The calcium-channel blocker, azelnidipine, enhances the inhibitory action of AT1 receptor blockade on ischemic brain damage J Hypertens 24 2006 2023 2031 (Pubitemid 44371270)
14. I. Masaru, I. Shinji, and T. Yumiko Attenuation of focal brain ischemia by telmisartan, an angiotensin II type 1 receptor blocker, in atherosclerotic apolipoprotein E-deficient mice Hypertens Res 31 2008 161 168
15. D. Butterfield, A. Castegna, and C. Pocernich Nutritional approaches to combat oxidative stress in Alzheimer's disease J Nutr Biochem 13 2002 444 461 (Pubitemid 34876979)
16. C. Ramassamy Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases: A review of their intracellular targets Eur J Pharmacol 545 2006 51 64
17. R.K. Maheshwari, A.K. Singh, and J. Gaddipati Multiple biological activities of curcumin: A short review Life Sci 78 2006 2081 2087
18. M. Thiyagarajan, and S.S. Sharma Neuroprotective effect of curcumin in middle cerebral artery occlusion-induced focal cerebral ischemia in rats Life Sci 74 2004 969 985 (Pubitemid 37522132)
19. M.K. Unnikrishnan, and M.N.A. Rao Curcumin inhibits nitrogen dioxide-induced oxidation of haemoglobin Mol Cell Biochem 146 1995 35 37
20. M. Subrmanian, N. Sreejayan, and M.N.A. Rao Diminution of singlet oxygen-induced DNA damage by curcumin and related antioxidants Mutat Res 311 1994 249 255 (Pubitemid 24357451)
21. G.J. Kelloff, J.A. Crowell, and E.T. Hawk Strategy and planning for chemopreventive drug development: Clinical development plans II J Cell Biochem 26 Suppl 1996 54 71 (Pubitemid 27203752)
22. S.M. Kim, L. Chen, and R. Faulhaber-Walter Regulation of renin secretion and expression in mice deficient in beta1- and beta2-adrenergic receptors Hypertension 50 2007 103 109 (Pubitemid 46986017)
23. B. Jin, and Y.-P. Li Curcumin prevents lipopolysaccharide-induced atrogin-1/MAFbx up-regulation and muscle mass loss J Cell Biochem 100 2007 960 969
24. E.Z. Longa, P.R. Weinstein, and S. Carlson Reversible middle cerebral artery occlusion without craniotomy in rats Stroke 20 1989 84 91 (Pubitemid 19040218)
25. S. Bouali, A. Evrard, and M. Chastanet Sex hormone-dependent desensitization of 5-HT 1A autoreceptors in knockout mice deficient in the 5-HT transporter Eur J Neurosci 18 2003 2203 2212 (Pubitemid 38117394)
26. J.B. Bederson, L.H. Pitts, and S.M. Germano Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarct size in rats Stroke 17 1986 1304 1308 (Pubitemid 17008976)
27. M. Uchiyama, and M. Mihara Determination of malonldehyde precursor in tissues by thiobarbituric acid test Anal Biochem 86 1978 271 278 (Pubitemid 9050395)
28. W.H. Habig, M.J. Pabst, and W.B. Jakoby Glutathione-S-transferase: The first enzymatic step in mereapturic acid formation J Biol Chem 249 1974 7130 7139
29. S.L. Marklund Pyrogallol auto-oxidation R.A. Greenwald, Handbook of Methods for Oxygen Radical Research 1985 CRC Press Boca Raton, FL 243 247
30. V. Raghavendra, J.N. Agrewala, and S.K. Kulkarni Melatonin reversal of lipopolysacharides-induced thermal and behavioural hyperalgesia in mice Eur J Pharmacol 395 2000 15 21 (Pubitemid 30227336)
31. O.H. Lowry, N.J. Rosebrough, and A.L. Forr Protein measurement with the Folin phenol reagent J Biol Chem 193 1951 265 275
32. P. Goehkle, W. Linz, and B.A. Sckolkens Cardiac and vascular effect of long-term losartan treatment in stroke-prone spontaneously hypertensive rats Hypertension 28 1996 397 402 (Pubitemid 26296041)
33. Y. Nishimura, T. Ito, and J.M. Saavedra Angiotensin II AT1 blockade normalizes cerebrovascular autoregulation and reduces cerebral ischemia in spontaneously hypertensive rats Stroke 31 2000 2478 2486
34. V.L. Pinto, T.M. Brunini, and M.R. Ferraz Depression and cardiovascular disease: Role of nitric oxide Cardiovasc Hematol Agents Med Chem 6 2008 142 149 (Pubitemid 351935021)
35. Y.Q. Zheng, J.X. Liu, and J.N. Wang Effects of crocin on reperfusion-induced oxidative/nitrative injury to cerebral microvessels after global cerebral ischemia Brain Res 1138 2007 86 94
36. V.P. Menon, and A.R. Sudheer Antioxidant and anti-inflammatory properties of curcumin Adv Exp Med Biol 595 2007 105 125
37. J.W. Kupiec-Weglinski, and R.W. Busuttil Ischemia and reperfusion injury in liver transplantation Transplant Proc 37 2005 1653 1656 (Pubitemid 40790787)
38. P. Boros, and J.S. Bromberg New cellular and molecular immune pathways in ischemia/reperfusion injury Am J Transplant 6 2006 652 658 (Pubitemid 43345001)
39. 1 receptors in permeability of the blood-brain barrier in diabetic hypertensive rats Vasc Pharmacol 45 2006 141 147 (Pubitemid 44716732)
40. M. Akhtar, K. Pillai, and D. Vohora Effect of thioperamide on oxidative stress markers in middle cerebral artery occlusion model of focal cerebral ischemia in rats Hum Exp Toxicol 27 2008 761 767
41. H. Chen, Y.S. Song, and P.H. Chan Inhibition of NADPH oxidase is neuroprotective after ischemia-reperfusion J Cereb Blood Flow Metab 7 2009 1262 1272
42. P.S. Naidu, A. Singh, and S.K. Kulkarni Effect of Withania somnifera root extract on haloperidol-induced orofacial dyskinesia: Possible mechanisms of action J Med Food 6 2003 107 114 (Pubitemid 37128471)
43. A. Arjuman, V. Nair, and H.N. Gopalakrishna Evaluation of the antioxidant potential of NR-ANX-C (a polyherbal formulation) and its individual constituents in reversing haloperidol-induced catalepsy in mice Ind J Pharmacol 39 2007 151 154 (Pubitemid 47094669)
44. J.S. Beckman The double-edged role of nitric oxide in brain function and superoxide- mediated injury J Dev Physiol 15 1991 53 59
45. A. Jain, J. Martensson, and E. Stole Glutathione deficiency leads to mitochondrial damage in brain Proc Natl Acad Sci USA 88 1991 1913 1917 (Pubitemid 21916337)
46. M. Cini, R.G. Fariello, and A. Bianchetti Studies on lipid peroxidation in the rat brain Neurochem Res 19 1994 283 288 (Pubitemid 24054798)
47. I. Kusaka, G. Kusaka, and C. Zhou Role of AT1 receptors and NAD (P) H oxidase in diabetes-aggravated ischemic brain injury Am J Physiol 286 2004 H2442 H2451 (Pubitemid 38685263)
48. A. Kumar, and A. Singh Possible nitric oxide modulation in protective effect of Curcuma longa Zingiberaceae against sleep deprivation-induced behavioral alterations and oxidative damage in mice Phytomedicine 15 2008 577 586
49. K. Pradeep, V.K. Shukla, and M. Khanna Anti-ischemic effect of curcumin in rat brain Neurochem Res 33 2008 1036 1043
50. J.M. Saavedra, and Y. Nishimura Angiotensin and cerebral blood flow Cell Mol Neurobiol 19 1999 553 573 (Pubitemid 29279739)
51. L. Edvinsson, J.E. Hardebo, and C. Owman Effects of angiotensin II on cerebral blood vessels Acta Physiol Scand 105 1979 381 383 (Pubitemid 9146729)
52. L. Näveri, C. Strömberg, and J.M. Saavedra Angiotensin II AT1 receptor-mediated contraction of the perfused rat cerebral artery Neuroreport 5 1994 2278 2280 (Pubitemid 24374854)
53. S.A. Griffin, W.C.B. Brown, and F. MacPherson Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism Hypertension 17 1991 626 635
54. T. Ito, H. Yamakawa, and C. Bregonzio Protection against ischemia and improvement of cerebral blood flow in genetically hypertensive rats by chronic pretreatment with an angiotensin II AT1 antagonist Stroke 33 2002 2297 2303 (Pubitemid 35014646)
55. M.A. Hajdu, D.D. Heistad, and S. Ghoneim Effects of antihypertensive treatment on composition of cerebral arterioles Hypertension 18 Suppl II 1991 1115 1121
56. T. Vraamak, G. Waldemar, and S. Strandgaard Angiotensin II receptor antagonist candesartan and cerebral blood flow autoregulation J Hypertens 13 1995 755 761
57. Y. Nishimura, T. Xu, and O. Jöhren The angiotensin AT1 receptor antagonist candesartan regulates cerebral blood flow and brain angiotensin AT1 receptor expression Basic Res Cardiol 93 Suppl 2 1998 63 68 (Pubitemid 28498134)
58. P. Shukla, V. Khanna, and M. Ali Anti-ischemic effect of curcumin in rat brain Neurochem Res 33 2008 1036 1043
59. M.H. Pan, T.M. Huang, and J.K. Lin Biotransformation of curcumin through reduction and glucuronidation in mice Drug Metab Dispos 27 1999 486 494
60. P.S. Tan, S. Killinger, and J. Horiuchi Baroreceptor reflex modulation by circulating angiotensin II is mediated by AT1 receptors in the nucleus tractus solitarius Am J Physiol Reg Integr Comp Physiol 293 2007 R2267 R2278 (Pubitemid 350224020)
61. H. Tsutsui, S. Matsushima, and S. Kinugawa Angiotensin II type 1 receptor blocker attenuates myocardial remodeling and preserves diastolic function in diabetic heart Hypertens Res 30 2007 439 449 (Pubitemid 46958894)
62. Y. Okano, K. Tamura, and T. Kuji Effects of angiotensin II receptor blockers on relationships between 24-hour blood pressure, autonomic function, and health-related QOL Clin Exp Hypertens 31 2009 250 258
63. T. Furukawa, T. Hatsuno, and Y. Ueno Relationship between decrease in ambulatory blood pressure and heart rate variability due to the effects of taking olmesartan medoxomil Clin Drug Invest 29 2009 257 264
64. N. Venkatesan Curcumin attenuation of acute adriamycin myocardial toxicity in rats Br J Pharmacol 124 1998 425 427 (Pubitemid 28254494)
65. C. Daosukho, Y. Chen, and T. Noel Phenylbutyrate, a histone deacetylase inhibitor, protects against adriamycin-induced cardiac injury Free Radic Biol Med 42 2007 1818 1825 (Pubitemid 46754756)